SuperworthTarsus Pharmaceuticals shares outstanding TARS
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 43.4M
- On a year earlier
- +2.4%
- more shares
Tarsus Pharmaceuticals had 43.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 42.8M | +11% |
| FY2024 | 38.6M | +16% |
| FY2023 | 33.3M | +25% |
| FY2022 | 26.7M | +29% |
| FY2021 | 20.7M | +24% |
| FY2020 | 16.7M | +565% |
| FY2019 | 2.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 43.4M | +2% | |
| Q1 FY26 | 43M | +9% | |
| Q4 FY25 | 42.8M | +11% | |
| Q3 FY25 | 42.6M | +11% | |
| Q2 FY25 | 42.4M | +12% | |
| Q1 FY25 | 39.3M | +11% | |
| Q4 FY24 | 38.6M | +16% | |
| Q3 FY24 | 38.4M | +25% | |
| Q2 FY24 | 37.8M | +41% | |
| Q1 FY24 | 35.3M | +32% | |
| Q4 FY23 | 33.3M | +25% | |
| Q3 FY23 | 30.6M | +15% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Tarsus Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.